Developer of antibody therapeutic solutions for the treatment of cancer. The company is involved in the development of IL-2 targeting antibodies that mainly known as Interleukin-2 (IL‑2) cytokine secreted by activated T-cells provides treatment solutions for solid tumors. It has a CD25 binding site that binds antibodies to the respective cancer cells.
← All startups
Aulos Bioscience
Series BDeveloper of antibody therapeutic solutions for the treatment of cancer. The company is involved in the development of IL-2 targeting antibodies that mainly known as Interleukin-2 (IL‑2) cytokine secreted by activated T-cells provides treatment solutions for solid tumors. It has a CD25 binding site that binds antibodies to the respective cancer cells.
About
Institutional investors
Apple Tree Partners
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.